Finance
HIMSS25
Gunnar Trommer of BCG X and Erik Adams of BCG give highlights of their upcoming HIMSS25 panel on the capital needed to develop and commercialize AI-powered medical devices and on completing regulatory milestones like 510(k) clearance.
The collaboration will provide funding, resources and market access to startups developing healthcare technologies expanding into the United States market from the U.K.
NeuroFlow will partner with Quartet’s customers to combine its capabilities aimed at improving the continuity and cost of care.
The company will use the funds to grow its handheld histotripsy therapy and expand its team.
At a Senate confirmation hearing, Kennedy said using AI and telemedicine in rural hospitals will be a priority if he is confirmed as the head of Health and Human Services.
CMS raised the payment for homecare by only a half a percent, and that does not compare to inflation, says Luke Rutledge, president of Homecare Homebase, who adds: "That does not equate to the costs that continue to rise for our customers."
The funds will be used to increase product offerings, expand the commercial team and move into the substance use disorder space.
Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer's disease and test that device in clinical trials.
The funds will be used to strengthen the development of its proprietary AI and enhance technology-enabled delivery of clinical trials.
The financing will be used to execute the company's long-term growth initiatives centered on high-margin, scalable recurring revenues across B2B and pharma channels.